Efficacies of amphotericin B (AMB) lipid complex, AMB colloidal dispersion, liposomal AMB, and conventional AMB in treatment of murine coccidioidomycosis. 2004

Gloria M González, and Rolando Tijerina, and Laura K Najvar, and Rosie Bocanegra, and Michael G Rinaldi, and John R Graybill
Department of Medicine, Division of Infectious Diseases, University of Texas Health Science Center at San Antonio, 78229-3900, USA. gmglez@yahoo.com.mx

The therapeutic efficacy of three lipid formulations of amphotericin B was compared with that of conventional amphotericin B in treatment of murine coccidioidomycosis. All treatments prolonged survival compared with the no-treatment group (P < 0.0001). Although conventional amphotericin B was more active than lipid formulations on reducing quantitative fungal load on a milligram-per-kilogram basis (P < 0.003 to 0.0002), the lipid preparations could be administered at higher doses, sterilizing liver and spleen tissues. The efficacies of the lipid preparations were similar in this murine model of coccidioidomycosis.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D003045 Coccidioides A mitosporic fungal genus which causes COCCIDIOIDOMYCOSIS. Coccidioides immitis
D003047 Coccidioidomycosis Infection with a fungus of the genus COCCIDIOIDES, endemic to the SOUTHWESTERN UNITED STATES. It is sometimes called valley fever but should not be confused with RIFT VALLEY FEVER. Infection is caused by inhalation of airborne, fungal particles known as arthroconidia, a form of FUNGAL SPORES. A primary form is an acute, benign, self-limited respiratory infection. A secondary form is a virulent, severe, chronic, progressive granulomatous disease with systemic involvement. It can be detected by use of COCCIDIOIDIN. Coccidioides Infection,Coccidioides posadasii Infection,Coccidioidomycosis Infection,Coccidioides immitis Infection,San Joaquin Valley Fever,Valley Fever,Coccidioides Infections,Coccidioides immitis Infections,Coccidioides posadasii Infections,Coccidioidomycoses,Coccidioidomycosis Infections,Infection, Coccidioides,Infection, Coccidioides immitis,Infection, Coccidioides posadasii,Infection, Coccidioidomycosis,Valley Fevers
D003102 Colloids Two-phase systems in which one is uniformly dispersed in another as particles small enough so they cannot be filtered or will not settle out. The dispersing or continuous phase or medium envelops the particles of the discontinuous phase. All three states of matter can form colloids among each other. Hydrocolloids,Colloid,Hydrocolloid
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Gloria M González, and Rolando Tijerina, and Laura K Najvar, and Rosie Bocanegra, and Michael G Rinaldi, and John R Graybill
September 1992, The Journal of antimicrobial chemotherapy,
Gloria M González, and Rolando Tijerina, and Laura K Najvar, and Rosie Bocanegra, and Michael G Rinaldi, and John R Graybill
February 2006, Antimicrobial agents and chemotherapy,
Gloria M González, and Rolando Tijerina, and Laura K Najvar, and Rosie Bocanegra, and Michael G Rinaldi, and John R Graybill
September 1991, Antimicrobial agents and chemotherapy,
Gloria M González, and Rolando Tijerina, and Laura K Najvar, and Rosie Bocanegra, and Michael G Rinaldi, and John R Graybill
June 2006, The Journal of antimicrobial chemotherapy,
Gloria M González, and Rolando Tijerina, and Laura K Najvar, and Rosie Bocanegra, and Michael G Rinaldi, and John R Graybill
October 1991, Antimicrobial agents and chemotherapy,
Gloria M González, and Rolando Tijerina, and Laura K Najvar, and Rosie Bocanegra, and Michael G Rinaldi, and John R Graybill
June 2011, Artificial organs,
Gloria M González, and Rolando Tijerina, and Laura K Najvar, and Rosie Bocanegra, and Michael G Rinaldi, and John R Graybill
January 1998, The Journal of infection,
Gloria M González, and Rolando Tijerina, and Laura K Najvar, and Rosie Bocanegra, and Michael G Rinaldi, and John R Graybill
May 2009, Antimicrobial agents and chemotherapy,
Gloria M González, and Rolando Tijerina, and Laura K Najvar, and Rosie Bocanegra, and Michael G Rinaldi, and John R Graybill
September 2001, Journal of chromatography. B, Biomedical sciences and applications,
Gloria M González, and Rolando Tijerina, and Laura K Najvar, and Rosie Bocanegra, and Michael G Rinaldi, and John R Graybill
February 2001, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!